SEC Form 4 · accession 0001567619-19-006351
NEVRO CORP · NVRO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Doug Alleavitch
Officer — VP, Quality
Period of report
Mar 5, 2019
Accepted (ET)
Mar 7, 2019 · 11:13 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001444380
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Mar 5, 2019 | M | 1,031 | $42.30 | A | 27,016 | D | |
| Common Stock | holding | — | — | — | 1,517 | I | By Spouse |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2 | $42.30 | Mar 5, 2019 | M | 1,031 | D | — | Nov 26, 2028 | Common Stock | 1,031 | 15,469 | D |
Explanation of responses
- F1Includes 14,792 restricted stock units.
- F21/48th of the shares subject to the option vest on each monthly anniversary measured from November 27, 2018 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.